$7.95
0.081.02%
At close: -
$7.88
-0.07-0.88%
After Hours: 6:26 PM EDT
Comments
Loading...
Latest Regulus Therapeutics Stock News | NASDAQ:RGLS | Benzinga
Get the latest news on Regulus Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Regulus Therapeutics performance
Categories: All
Thursday, May 08, 2025
Thursday, May 01, 2025
Wednesday, April 30, 2025
- Jones Trading Downgrades Regulus Therapeutics...
- Canaccord Genuity Downgrades Regulus Therapeu...
- 12 Health Care Stocks Moving In Wednesday's Intraday Session
- Crude Oil Falls Over 3%; Regulus Therapeutics Shares Spike Higher
- Novartis To Buy US Kidney Drug Developer Regulus Therapeutics For Around $800 Million
- S&P 500 Falls 2%; Caterpillar Reports Downbeat Q1 Results
- Regulus Therapeutics shares are trading highe...
- 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- Trading Halt: Halt status updated at 7:25:00 ...
- Novartis To Buy Regulus Therapeutics For $7.0...
- Trading Halt: Halted at 6:55:00 a.m. ET - Tra...
Thursday, March 27, 2025
- Wells Fargo Upgrades Regulus Therapeutics to ...
- 12 Health Care Stocks Moving In Thursday's Intraday Session
- Regulus Therapeutics Stock Shoots Higher After Positive Results From Investigational Drug For Rare Type Of Kidney Disease
- Regulus Therapeutics shares are trading highe...
- 12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Regulus Therapeutics Announced Topline Result...
